drugset / Trial / NCT02422030
CKD-337(2) Drug-drug Interaction Study
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic interaction between Atorvastatin and Fenofibric acid.
Timeline
- Start
- 2015-03-17
- Primary completion
- 2015-03-22
- Completion
- 2015-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | fenofibric acid | Small molecule | 135 mg | — |
Indications
No indication recorded.